TiGenix's Pending Acquisition

TiGenix raised a round of funding on January 05, 2018. Investors include Takeda Pharmaceutical.

TiGenix (NYSE Euronext: TIG) is a European cell therapy company with an advanced clinical stage pipeline of adult stem cell programs, and a commercialized product.…

Articles about TiGenix's Pending Acquisition: